Ebenezer IS, Vellucci SV, Parrott RF (2001) The differential effects of intravenously administered 8-OH-DPAT on operant food intake in satiated and food-deprived pigs are mediated by central 5-HT(1A) receptors. Physiol Behav 73: 223-227
Edgemond WS, Campbell WB, Hillard CJ (1995) The binding of novel phenolic derivatives of anandamide to brain cannabinoid receptors. Prostaglandins Leukot Essent Fatty Acids 52: 83-86
Edgemond WS, Greenberg MJ, McGinley PJ, Muthian S, Campbell WB, Hillard CJ (1998) Synthesis and characterization of diazomethylarachidonyl ketone: an irreversible inhibitor of N-arachidonylethanolamine amidohydrolase. J Pharmacol Exp Ther 286: 184-190
Edgemond WS, Hillard CJ, Falck JR, Kearn CS, Campbell WB (1998) Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. Mol Pharmacol 54: 180-188
Edsall SA, Knapp RJ, Vanderah TW, Roeske WR, Consroe P, Yamamura HI (1996) Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociception. Neuroreport 7: 593-596
Edwards G, Weston AH (1998) Endothelium-derived hyperpolarizing factor--a critical appraisal. Prog Drug Res 50: 107-133
Egashira N, Mishima K, Uchida T, Hasebe N, Nagai H, Mizuki A, Iwasaki K, Ishii H, Nishimura R, Shoyama Y, Fujiwara M (2004) Anandamide inhibits the DOI-induced head-twitch response in mice. Psychopharmacology (Berl) 171: 382-389
Egertova M, Cravatt BF, Elphick MR (2000) Fatty acid amide hydrolase expression in rat choroid plexus: possible role in regulation of the sleep-inducing action of oleamide. Neurosci Lett 282: 13-16
Egertova M, Cravatt BF, Elphick MR (2003) Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience 119: 481-496
Egertova M, Giang DK, Cravatt BF, Elphick MR (1998) A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc R Soc Lond B Biol Sci 265: 2081-2085
Ehrlich BE (1995) Functional properties of intracellular calcium-release channels. Curr Opin Neurobiol 5: 304-309
Ehrlich BE, Bezprozvanny I (1994) Intracellular calcium release channels. Chin J Physiol 37: 1-7
Ehrlich BE, Watras J (1988) Inositol 1,4,5-trisphosphate activates a channel from smooth muscle sarcoplasmic reticulum. Nature 336: 583-586
Eilers J, Konnerth A (1997) Dendritic signal integration. Curr Opin Neurobiol 7: 385-390
Eilers J, Plant T, Konnerth A (1996) Localized calcium signalling and neuronal integration in cerebellar Purkinje neurones. Cell Calcium 20: 215-226
El-Gohary M, Eid MA (2004) Effect of cannabinoid ingestion (in the form of bhang) on the immune system of high school and university students. Hum Exp Toxicol 23: 149-156
El-Remessy AB, Khalil IE, Matragoon S, Abou-Mohamed G, Tsai NJ, Roon P, Caldwell RB, Caldwell RW, Green K, Liou GI (2003) Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite. Am J Pathol 163: 1997-2008
El Bawab S, Usta J, Roddy P, Szulc ZM, Bielawska A, Hannun YA (2002) Substrate specificity of rat brain ceramidase. J Lipid Res 43: 141-148
El Fangour S, Balas L, Rossi JC, Fedenyuk A, Gretskaya N, Bobrov M, Bezuglov V, Hillard CJ, Durand T (2003) Hemisynthesis and preliminary evaluation of novel endocannabinoid analogues. Bioorg Med Chem Lett 13: 1977-1980
Ellingson JS (1980) Identification of N-acylethanolamine phosphoglycerides and acylphosphatidylglycerol as the phospholipids which disappear as Dictyostelium discoideum cells aggregate. Biochemistry 19: 6176-6182
Ellingson JS, Dischinger HC (1985) Concurrent disappearance of N-acylethanolamine glycerophospholipids and phagolysosomes enriched in N-acylethanolamine glycerophospholipids as Dictyostelium discoideum cells aggregate. Biochim Biophys Acta 812: 255-260
Ellington HC, Cotter MA, Cameron NE, Ross RA (2002) The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats. Neuropharmacology 42: 966-975
Elliott AC, Cairns SP, Allen DG (1992) Subcellular gradients of intracellular free calcium concentration in isolated lacrimal acinar cells. Pflugers Arch 422: 245-252
Ellis EF, Moore SF, Willoughby KA (1995) Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin. Am J Physiol 269: H1859-1864
Ellis PD, Hadfield KM, Pascall JC, Brown KD (2000) Cyclic AMP inhibits agonist-induced heparin-binding EGF gene expression independently of effects on p42/p44 MAPK activation. Biochem Biophys Res Commun 277: 558-561
Elmes SJR, Smart D, David KA, Victoria C (2003) Role of CB2 receptors in peripheral somatosensory processing. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Elphick MR, Egertova M (2001) The neurobiology and evolution of cannabinoid signalling. Philos Trans R Soc Lond B Biol Sci 356: 381-408
Elphick MR, Satou Y, Satoh N (2003) The invertebrate ancestry of endocannabinoid signalling: an orthologue of vertebrate cannabinoid receptors in the urochordate Ciona intestinalis. Gene 302: 95-101
Emrich HM, Leweke FM, Schneider U (1997) Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacol Biochem Behav 56: 803-807
Epps DE, Natarajan V, Schmid PC, Schmid HO (1980) Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium. Biochim Biophys Acta 618: 420-430
Epps DE, Schmid PC, Natarajan V, Schmid HH (1979) N-Acylethanolamine accumulation in infarcted myocardium. Biochem Biophys Res Commun 90: 628-633
Esmaeili B, Ross JM, Neades C, Miller DM, 3rd, Ahringer J (2002) The C. elegans even-skipped homologue, vab-7, specifies DB motoneurone identity and axon trajectory. Development 129: 853-862
Esposito G, Izzo AA, Di Rosa M, Iuvone T (2001) Selective cannabinoid CB1 receptor-mediated inhibition of inducible nitric oxide synthase protein expression in C6 rat glioma cells. J Neurochem 78: 835-841
Esposito G, Ligresti A, Izzo AA, Bisogno T, Ruvo M, Di Rosa M, Di Marzo V, Iuvone T (2002) The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity - Mechanism and regulation. Journal of Biological Chemistry 277: 50348-50354
Esposito G, Ligresti A, Izzo AA, Bisogno T, Ruvo M, Di Rosa M, Di Marzo V, Iuvone T (2002) The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity. Mechanism and regulation. J Biol Chem 277: 50348-50354
Evans MG, Marty A (1986) Calcium-dependent chloride currents in isolated cells from rat lacrimal glands. J Physiol 378: 437-460
Evans MG, Marty A (1986) Potentiation of muscarinic and alpha-adrenergic responses by an analogue of guanosine 5'-triphosphate. Proc Natl Acad Sci U S A 83: 4099-4103
Evans MG, Marty A, Tan YP, Trautmann A (1986) Blockage of Ca-activated Cl conductance by furosemide in rat lacrimal glands. Pflugers Arch 406: 65-68
Evans PC, Ovaa H, Hamon M, Kilshaw PJ, Hamm S, Bauer S, Ploegh HL, Smith TS (2004) Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem J 378: 727-734
Evans PC, Taylor ER, Coadwell J, Heyninck K, Beyaert R, Kilshaw PJ (2001) Isolation and characterization of two novel A20-like proteins. Biochem J 357: 617-623
Evans RM, Scott RH, Ross RA (2004) Multiple actions of anandamide on neonatal rat cultured sensory neurones. Br J Pharmacol 141: 1223-1233
Facchinetti F, Del Giudice E, Furegato S, Passarotto M, Leon A (2003) Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide. Glia 41: 161-168
Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A (1995) Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci U S A 92: 3376-3380
Fajloun Z, Kharrat R, Chen L, Lecomte C, Di Luccio E, Bichet D, El Ayeb M, Rochat H, Allen PD, Pessah IN, De Waard M, Sabatier JM (2000) Chemical synthesis and characterization of maurocalcine, a scorpion toxin that activates Ca(2+) release channel/ryanodine receptors. FEBS Lett 469: 179-185
Fan P (1995) Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons. J Neurophysiol 73: 907-910
Fan S, Ma YX, Gao M, Yuan RQ, Meng Q, Goldberg ID, Rosen EM (2001) The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair. Mol Cell Biol 21: 4968-4984
Fan SF, Yazulla S (2003) Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB1 receptor agonist WIN 55212-2. Vis Neurosci 20: 177-188
Faraco PR, Ledgerwood EC, Vandenabeele P, Prins JB, Bradley JR (1999) Tumor necrosis factor induces distinct patterns of caspase activation in WEHI-164 cells associated with apoptosis or necrosis depending on cell cycle stage. Biochem Biophys Res Commun 261: 385-392
Farndale RW, Siljander PR, Onley DJ, Sundaresan P, Knight CG, Barnes MJ (2003) Collagen-platelet interactions: recognition and signalling. Biochem Soc Symp: 81-94
Farooqi IS, O'Rahilly S (2000) Recent advances in the genetics of severe childhood obesity. Arch Dis Child 83: 31-34
Farooqi IS, O'Rahilly S (2004) Monogenic human obesity syndromes. Recent Prog Horm Res 59: 409-424
Farquhar-Smith WP, Jaggar SI, Rice AS (2002) Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. Pain 97: 11-21
Farquhar-Smith WP, Rice AS (2001) Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder. Anesthesiology 94: 507-513; discussion 506A
Farquhar-Smith WP, Rice AS (2003) A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia. Anesthesiology 99: 1391-1401
Farrens DL, Dunham TD, Fay JF, Dews IC, Caldwell J, Nauert B (2002) Design, expression, and characterization of a synthetic human cannabinoid receptor and cannabinoid receptor/ G-protein fusion protein. J Pept Res 60: 336-347
Farzaneh-Far A, Proudfoot D, Weissberg PL, Shanahan CM (2000) Matrix gla protein is regulated by a mechanism functionally related to the calcium-sensing receptor. Biochem Biophys Res Commun 277: 736-740
Fasia L, Karava V, Siafaka-Kapadai A (2003) Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter? Eur J Biochem 270: 3498-3506
Fasia L, Karava V, Siafaka-Kapadai A (2003) Uptake and metabolism of [H-3]anandamide by rabbit platelets - Lack of transporter? European Journal of Biochemistry 270: 3498-3506
Fassio A, Evans G, Grisshammer R, Bolam JP, Mimmack M, Emson PC (2000) Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody. Neuropharmacology 39: 1430-1442
Fattore L, Cossu G, Martellotta CM, Fratta W (2001) Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats. Psychopharmacology (Berl) 156: 410-416
Fattore L, Martellotta MC, Cossu G, Mascia MS, Fratta W (1999) CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats. Behav Brain Res 104: 141-146
Fearon IM, Zhang M, Vollmer C, Nurse CA (2003) GABA mediates autoreceptor feedback inhibition in the rat carotid body via presynaptic GABAB receptors and TASK-1. J Physiol 553: 83-94
Fedorova I, Hashimoto A, Fecik RA, Hedrick MP, Hanus LO, Boger DL, Rice KC, Basile AS (2001) Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems. J Pharmacol Exp Ther 299: 332-342
Fegley D, Giuffrida A, Leweke FM, Gerth CV, Faulhaber J, Klosterktter J, Piomelli D (2002) Elevated Csf Anandamide Is Selective for Acute Schizophrenia and Negatively Correlates with Psychotic Symptoms. Society for Neuroscience Abstract Viewer and Itinerary Planner 2002
Fegley D, Kathuria S, Picone R, Li C, Goutopoulos A, Makriyannis A, Piomelli D (2003) A novel inhibitor of endocannabinoid transport that does not affect anandamide hydrolysis. further evidence for the existence of an endocannabinoid transporter. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Fehervari Z, Cooke A, Brett S, Turner J (2002) Perturbation of naive TCR transgenic T cell functional responses and upstream activation events by anti-CD4 monoclonal antibodies. Eur J Immunol 32: 333-340
Feil R, Khosla S, Cappai P, Loi P (1998) Genomic imprinting in ruminants: allele-specific gene expression in parthenogenetic sheep. Mamm Genome 9: 831-834
Felder CC, Briley EM, Axelrod J, Simpson JT, Mackie K, Devane WA (1993) Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc Natl Acad Sci U S A 90: 7656-7660
Felder CC, Glass M (1998) Cannabinoid receptors and their endogenous agonists. Annu Rev Pharmacol Toxicol 38: 179-200
Felder CC, Joyce KE, Briley EM, Glass M, Mackie KP, Fahey KJ, Cullinan GJ, Hunden DC, Johnson DW, Chaney MO, Koppel GA, Brownstein M (1998) LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. J Pharmacol Exp Ther 284: 291-297
Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL, Mitchell RL (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48: 443-450
Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, Nguyen DN, Richardson JM, Riggin RM, Koppel GA, Paul SM, Becker GW (1996) Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett 393: 231-235
Fenelon VS, Herbison AE (2000) Progesterone regulation of GABAA receptor plasticity in adult rat supraoptic nucleus. Eur J Neurosci 12: 1617-1623
Feng W, Cai J, Pierce WM, Jr., Song ZH (2002) Expression of CB2 cannabinoid receptor in Pichia pastoris. Protein Expr Purif 26: 496-505
Feng W, Song ZH (2001) Functional roles of the tyrosine within the NP(X)(n)Y motif and the cysteines in the C-terminal juxtamembrane region of the CB2 cannabinoid receptor. FEBS Lett 501: 166-170
Feng W, Song ZH (2003) Effects of D3.49A, R3.50A, and A6.34E mutations on ligand binding and activation of the cannabinoid-2 (CB2) receptor. Biochem Pharmacol 65: 1077-1085
Feniuk W, Jarvie E, Luo J, Humphrey PP (2000) Selective somatostatin sst(2) receptor blockade with the novel cyclic octapeptide, CYN-154806. Neuropharmacology 39: 1443-1450
Fernandez-Espejo E, Caraballo I, Rodriguez De Fonseca F, Ferrer B, Banoua FE, Flores JA, Galan-Rodriguez B (2004) Experimental Parkinsonism Alters Anandamide Precursor Synthesis, and Functional Deficits are Improved by AM404: A Modulator of Endocannabinoid Function. Neuropsychopharmacology
Fernandez-Espejo E, Galan-Rodriguez B (2004) Sensorimotor gating in mice is disrupted after AM404, an anandamide reuptake and degradation inhibitor. Psychopharmacology (Berl)
Fernandez-Patron C, Stewart KG, Zhang Y, Koivunen E, Radomski MW, Davidge ST (2000) Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res 87: 670-676
Fernandez-Ruiz J, Berrendero F, Hernandez ML, Ramos JA (2000) The endogenous cannabinoid system and brain development. Trends Neurosci 23: 14-20
Fernandez-Ruiz J, Lastres-Becker I, Cabranes A, Gonzalez S, Ramos JA (2002) Endocannabinoids and basal ganglia functionality. Prostaglandins Leukot Essent Fatty Acids 66: 257-267
Fernandez-Ruiz JJ, Berrendero F, Hernandez ML, Romero J, Ramos JA (1999) Role of endocannabinoids in brain development. Life Sci 65: 725-736
Fernandez-Ruiz JJ, Munoz RM, Romero J, Villanua MA, Makriyannis A, Ramos JA (1997) Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics. Biochem Pharmacol 53: 1919-1927
Fernandez-Solari J, Scorticati C, Mohn C, De Laurentiis A, Billi S, Franchi A, McCann SM, Rettori V (2004) Alcohol inhibits luteinizing hormone-releasing hormone release by activating the endocannabinoid system. Proc Natl Acad Sci U S A 101: 3264-3268
Fernando SR, Pertwee RG (1997) Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist. Br J Pharmacol 121: 1716-1720
Ferraguti F, Corti C, Valerio E, Mion S, Xuereb J (2001) Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2/3 and 5. Exp Brain Res 137: 1-11
Ferrari MB, Spitzer NC (1999) Calcium signaling in the developing Xenopus myotome. Dev Biol 213: 269-282
Ferrer B, Asbrock N, Kathuria S, Piomelli D, Giuffrida A (2003) Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. Eur J Neurosci 18: 1607-1614
Ferry G, Boutin JA, Hennig P, Genton A, Desmet C, Fauchere JL, Atassi G, Tucker GC (1998) A zinc chelator inhibiting gelatinases exerts potent in vitro anti-invasive effects. Eur J Pharmacol 351: 225-233
Fezza F, Bisogno T, Minassi A, Appendino G, Mechoulam R, Di Marzo V (2002) Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues. FEBS Lett 513: 294-298
Fezza F, Dillwith JW, Bisogno T, Tucker JS, Di Marzo V, Sauer JR (2003) Endocannabinoids and related fatty acid amides, and their regulation, in the salivary glands of the lone star tick. Biochim Biophys Acta 1633: 61-67
Fichera M, Cruciani G, Bianchi A, Musumarra G (2000) A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors. J Med Chem 43: 2300-2309
Field FJ, Albright E, Mathur S (1991) Inhibition of acylcoenzyme A: cholesterol acyltransferase activity by PD128O42: effect on cholesterol metabolism and secretion in CaCo-2 cells. Lipids 26: 1-8
Field MJ, McCleary S, Boden P, Suman-Chauhan N, Hughes J, Singh L (1998) Involvement of the central tachykinin NK1 receptor during maintenance of mechanical hypersensitivity induced by diabetes in the rat. J Pharmacol Exp Ther 285: 1226-1232
Fields HL, Meng ID (1998) Watching the pot boil. Nat Med 4: 1008-1009
Filipeanu CM, de Zeeuw D, Nelemans SA (1997) Delta9-tetrahydrocannabinol activates [Ca2+]i increases partly sensitive to capacitative store refilling. Eur J Pharmacol 336: R1-3
Filipowicz-Banachowa A (1991) [Pathological changes found in the lacrimal sac during nasolacrimal duct surgery]. Klin Oczna 93: 89-90
Filippov AK, Brown DA, Barnard EA (2000) The P2Y(1) receptor closes the N-type Ca(2+) channel in neurones, with both adenosine triphosphates and diphosphates as potent agonists. Br J Pharmacol 129: 1063-1066
Filippov AK, Couve A, Pangalos MN, Walsh FS, Brown DA, Moss SJ (2000) Heteromeric assembly of GABA(B)R1 and GABA(B)R2 receptor subunits inhibits Ca(2+) current in sympathetic neurons. J Neurosci 20: 2867-2874
Fimiani C, Magazine H, Welters ID, Bilfinger TV, Salsano F, Tonnesen E, Stefano GB (2000) Antagonism of LPS and IFN-gamma induced iNOS expression in human atrial endothelia by morphine, anandamide, and estrogen. Acta Pharmacol Sin 21: 405-409
Fimiani C, Mattocks D, Cavani F, Salzet M, Deutsch DG, Pryor S, Bilfinger TV, Stefano GB (1999) Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. Cell Signal 11: 189-193
Findlay I (1984) A patch-clamp study of potassium channels and whole-cell currents in acinar cells of the mouse lacrimal gland. J Physiol 350: 179-195
Findlay I, Petersen OH (1985) Acetylcholine stimulates a Ca2+-dependent C1- conductance in mouse lacrimal acinar cells. Pflugers Arch 403: 328-330
Fiskum G (2000) Mitochondrial participation in ischemic and traumatic neural cell death. J Neurotrauma 17: 843-855
Fitzgerald RC, Onwuegbusi BA, Bajaj-Elliott M, Saeed IT, Burnham WR, Farthing MJ (2002) Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut 50: 451-459
Fleming I, Schermer B, Popp R, Busse R (1999) Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists. Br J Pharmacol 126: 949-960
Fleming JT, Squire MD, Barnes TM, Tornoe C, Matsuda K, Ahnn J, Fire A, Sulston JE, Barnard EA, Sattelle DB, Lewis JA (1997) Caenorhabditis elegans levamisole resistance genes lev-1, unc-29, and unc-38 encode functional nicotinic acetylcholine receptor subunits. J Neurosci 17: 5843-5857
Fletcher AJ, Ma XH, Wu WX, Nathanielsz PW, McGarrigle HH, Fowden AL, Giussani DA (2004) Antenatal glucocorticoids reset the level of baseline and hypoxemia-induced pituitary-adrenal activity in the sheep fetus during late gestation. Am J Physiol Endocrinol Metab 286: E311-319
Fletcher EL, Hack I, Brandstatter JH, Wassle H (2000) Synaptic localization of NMDA receptor subunits in the rat retina. J Comp Neurol 420: 98-112
Fletcher GC, Xue L, Passingham SK, Tolkovsky AM (2000) Death commitment point is advanced by axotomy in sympathetic neurons. J Cell Biol 150: 741-754
Floto RA, Smith KG (2003) The vagus nerve, macrophages, and nicotine. Lancet 361: 1069-1070
Floto RA, Somasundaram B, Allen JM, Mahaut-Smith MP (1997) Fcgamma receptor I activation triggers a novel Ca2+-activated current selective for monovalent cations in the human monocytic cell line, U937. J Biol Chem 272: 4753-4758
Fontana A, Di Marzo V, Cadas H, Piomelli D (1995) Analysis of anandamide, an endogenous cannabinoid substance, and of other natural N-acylethanolamines. Prostaglandins Leukot Essent Fatty Acids 53: 301-308
Fontana L, Moreira E, Torres MI, Fernandez I, Rios A, Sanchez de Medina F, Gil A (1998) Dietary nucleotides correct plasma and liver microsomal fatty acid alterations in rats with liver cirrhosis induced by oral intake of thioacetamide. J Hepatol 28: 662-669
Ford WR, Honan SA, White R, Hiley CR (2002) Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts. Br J Pharmacol 135: 1191-1198
Forhead AJ, Broughton Pipkin F, Fowden AL (2000) Effect of cortisol on blood pressure and the renin-angiotensin system in fetal sheep during late gestation. J Physiol 526 Pt 1: 167-176
Forhead AJ, Fowden AL (2004) Role of angiotensin II in the pressor response to cortisol in fetal sheep during late gestation. Exp Physiol 89: 323-329
Forhead AJ, Li J, Gilmour RS, Dauncey MJ, Fowden AL (2002) Thyroid hormones and the mRNA of the GH receptor and IGFs in skeletal muscle of fetal sheep. Am J Physiol Endocrinol Metab 282: E80-86
Forhead AJ, Li J, Saunders JC, Dauncey MJ, Gilmour RS, Fowden AL (2000) Control of ovine hepatic growth hormone receptor and insulin-like growth factor I by thyroid hormones in utero. Am J Physiol Endocrinol Metab 278: E1166-1174
Forman LJ (2003) The effect of cannabinoid receptor antagonism with SR141716A on antinociception induced by cocaine and the NMDA receptor antagonist, MK-801. Brain Res Bull 61: 153-158
Fortin DA, Trettel J, Levine ES (2003) Action potential-induced suppression of inhibition in the neocortex is mediated by the release of endogenous cannabinoids. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Fowler CJ (2003) Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents. Non-psychoactive cannabinoids, 'entourage' compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid pyschotropic effects. Brain Res Brain Res Rev 41: 26-43
Fowler CJ (2004) Oleamide: a member of the endocannabinoid family? Br J Pharmacol 141: 195-196
Fowler CJ (2004) Possible involvement of the endocannabinoid system in the actions of three clinically used drugs. Trends Pharmacol Sci 25: 59-61
Fowler CJ, Borjesson M, Tiger G (2000) Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase. Br J Pharmacol 131: 498-504
Fowler CJ, Holt S, Tiger G (2003) Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner. J Enzyme Inhib Med Chem 18: 55-58
Fowler CJ, Jacobsson SO (2002) Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development? Prostaglandins Leukot Essent Fatty Acids 66: 193-200
Fowler CJ, Janson U, Johnson RM, Wahlstrom G, Stenstrom A, Norstrom K, Tiger G (1999) Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen. Arch Biochem Biophys 362: 191-196
Fowler CJ, Jonsson KO, Andersson A, Juntunen J, Jarvinen T, Vandevoorde S, Lambert DM, Jerman JC, Smart D (2003) Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid. Biochem Pharmacol 66: 757-767
Fowler CJ, Jonsson KO, Andersson AS, Jacobsson SOP (2002) Non - Specific Effects of Anandamide Uptake Inhibitors Upon C6 Glioma Cell Proliferation. Society for Neuroscience Abstract Viewer and Itinerary Planner 2002
Fowler CJ, Jonsson KO, Tiger G (2001) Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide. Biochem Pharmacol 62: 517-526
Fowler CJ, Karlsson M (2003) Anandamide binding to and release from cell culture wells is affected by uptake inhibitors. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Fowler CJ, Nilsson O, Andersson M, Disney G, Jacobsson SO, Tiger G (2001) Pharmacological properties of cannabinoid receptors in the avian brain: similarity of rat and chicken cannabinoid1 receptor recognition sites and expression of cannabinoid2 receptor-like immunoreactivity in the embryonic chick brain. Pharmacol Toxicol 88: 213-222
Fowler CJ, Stenstrom A, Tiger G (1997) Ibuprofen inhibits the metabolism of the endogenous cannabimimetic agent anandamide. Pharmacol Toxicol 80: 103-107
Fowler CJ, Tiger G, Lopez-Rodriguez ML, Viso A, Ortega-Gutierrez S, Ramos JA (2003) Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin. J Enzyme Inhib Med Chem 18: 225-231
Fowler CJ, Tiger G, Stenstrom A (1997) Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship. J Pharmacol Exp Ther 283: 729-734
Franke TF, Kaplan DR, Cantley LC (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88: 435-437
Franklin A, Parmentier-Batteur S, Walter L, Greenberg DA, Stella N (2003) Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J Neurosci 23: 7767-7775
Franklin A, Stella N (2003) Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors. Eur J Pharmacol 474: 195-198
Frearson JA, Alexander DR (1998) The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells. J Exp Med 187: 1417-1426
Freedland CS, Sharpe AL, Samson HH, Porrino LJ (2001) Effects of SR141716A on ethanol and sucrose self-administration. Alcohol Clin Exp Res 25: 277-282
Freeman M (2002) A fly's eye view of EGF receptor signalling. Embo J 21: 6635-6642
Freeman M, Gurdon JB (2002) Regulatory principles of developmental signaling. Annu Rev Cell Dev Biol 18: 515-539
Freeman W, Morton AJ (2004) Differential messenger RNA expression of complexins in mouse brain. Brain Res Bull 63: 33-44
Freestone JF, Seahorn TL (1993) Miscellaneous conditions of the equine head. Vet Clin North Am Equine Pract 9: 235-242
French ED (1997) delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neurosci Lett 226: 159-162
Freund TF, Hajos N (2003) Excitement reduces inhibition via endocannabinoids. Neuron 38: 362-365
Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83: 1017-1066
Fride E (1995) Anandamides: tolerance and cross-tolerance to delta 9-tetrahydrocannabinol. Brain Res 697: 83-90
Fride E (2002) Endocannabinoids in the central nervous system--an overview. Prostaglandins Leukot Essent Fatty Acids 66: 221-233
Fride E (2002) Endocannabinoids in the central nervous system - an overview. Prostaglandins Leukotrienes and Essential Fatty Acids 66: 221-233
Fride E (2002) Endocannabinoids in the central nervous system: An overview. Prostaglandins Leukotrienes and Essential Fatty Acids 66: 221-233
Fride E, Barg J, Levy R, Saya D, Heldman E, Mechoulam R, Vogel Z (1995) Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol. J Pharmacol Exp Ther 272: 699-707
Fride E, Ezra D, Suris R, Weisblum R, Blau H, Feigin C (2003) Role of CB1 receptors in emission of ultrasonic distress calls and body temperature in neonates. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Fride E, Foox A, Rosenberg E, Faigenboim M, Cohen V, Barda L, Blau H, Mechoulam R (2003) Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor. Eur J Pharmacol 461: 27-34
Fride E, Ginzburg Y, Breuer A, Bisogno T, Di Marzo V, Mechoulam R (2001) Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. Eur J Pharmacol 419: 207-214
Fride E, Mechoulam R (1993) Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur J Pharmacol 231: 313-314
Fride E, Mechoulam R (1996) Developmental aspects of anandamide: ontogeny of response and prenatal exposure. Psychoneuroendocrinology 21: 157-172
Fride E, Mechoulam R (1996) Ontogenetic development of the response to anandamide and delta 9-tetrahydrocannabinol in mice. Brain Res Dev Brain Res 95: 131-134
Fride E, Mechoulam R (2003) New advances in the identification and physiological roles of the components of the endogenous cannabinoid system. In Molecular biology of drug addiction, pp 173-197
Fride E, Shohami E (2002) The endocannabinoid system: function in survival of the embryo, the newborn and the neuron. Neuroreport 13: 1833-1841
Fride EC, Hanus L, Mechoulam R (2001) Role of endocannabinoids in food intake and development after birth: CB1 receptor specificity. Society for Neuroscience Abstracts 27
Fritzsche M (2001) Are cannabinoid receptor knockout mice animal models for schizophrenia? Med Hypotheses 56: 638-643
Fritzsche M (2003) The origin of brain asymmetry and its psychotic reversal. Med Hypotheses 60: 468-480
Froehner SC (1993) Regulation of ion channel distribution at synapses. Annu Rev Neurosci 16: 347-368
Froemke RC, Li CY, Dan Y (2003) A form of presynaptic coincidence detection. Neuron 39: 579-581
Frol'kis VV, Artamonov MV, Zhukov OD, Klimashevs'kii VM, Marhitych VM, Hula NM (2000) [Influence of saturated long-chain N-acylethanolamines on lipid composition and heart contractility of isolated rat heart under ischemia-reperfusion]. Ukr Biokhim Zh 72: 56-63
Frolkis VV, Artamonov MV, Zhukov AD, Klimashevsky VM, Margitich VM, Gulaya NM (2000) Influence of the saturated long-chain N-acylethanolamines on lipid composition and heart contractility of isolated rat heart under ischemia-reperfusion. Ukrainskii Biokhimicheskii Zhurnal 72: 56-63
Frost EE, Buttery PC, Milner R, ffrench-Constant C (1999) Integrins mediate a neuronal survival signal for oligodendrocytes. Curr Biol 9: 1251-1254
Fruen BR, Mickelson JR, Louis CF (1997) Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors. J Biol Chem 272: 26965-26971
Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodriguez De Fonseca F, Rosengarth A, Luecke H, Di Giacomo B, Tarzia G, Piomelli D (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425: 90-93
Fujiwara M (2001) [Characteristics of abnormal behavior induced by delta 9-tetrahydrocannabinol in rats]. Nippon Yakurigaku Zasshi 117: 35-41
Fulceri R, Rossi R, Bottinelli R, Conti A, Intravaia E, Galione A, Benedetti A, Sorrentino V, Reggiani C (2001) Ca2+ release induced by cyclic ADP ribose in mice lacking type 3 ryanodine receptor. Biochem Biophys Res Commun 288: 697-702
Fulton D, Quilley J (1998) Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat. J Pharmacol Exp Ther 286: 1146-1151
Fulton KF, Jackson SE, Buckle AM (2003) Energetic and structural analysis of the role of tryptophan 59 in FKBP12. Biochemistry 42: 2364-2372
Funabashi H, Kawaguchi A, Tomoda H, Omura S, Okuda S, Iwasaki S (1989) Binding site of cerulenin in fatty acid synthetase. J Biochem (Tokyo) 105: 751-755
Furlan RL, Ng YF, Otto S, Sanders JK (2001) A new cyclic pseudopeptide receptor for Li+ from a dynamic combinatorial library. J Am Chem Soc 123: 8876-8877
Furuichi T, Yoshikawa S, Mikoshiba K (1989) Nucleotide sequence of cDNA encoding P400 protein in the mouse cerebellum. Nucleic Acids Res 17: 5385-5386
Furuichi T, Yoshikawa S, Miyawaki A, Wada K, Maeda N, Mikoshiba K (1989) Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400. Nature 342: 32-38
Furuyashiki T, Fujisawa K, Fujita A, Madaule P, Uchino S, Mishina M, Bito H, Narumiya S (1999) Citron, a Rho-target, interacts with PSD-95/SAP-90 at glutamatergic synapses in the thalamus. J Neurosci 19: 109-118
Fusco FR, Martorana A, De March Z, Viscomi MT, Sancesario G, Bernardi G (2003) Huntingtin distribution among striatal output neurons of normal rat brain. Neurosci Lett 339: 53-56
Fyk-Kolodziej B, Qin P, Pourcho RG (2003) Identification of a cone bipolar cell in cat retina which has input from both rod and cone photoreceptors. J Comp Neurol 464: 104-113